Basic and clinicopathological data for the patients entered in the study
| All patients | PPI | 0–40 | 41–50 | 51–60 | 61–70 | 71–80 | >80 | |
|---|---|---|---|---|---|---|---|---|
| The data are given for all the patients (439; mean age 55 (range 17–88)), patients who had been taking proton pump inhibitors for ⩾6 months (PPI) (65; mean age 62 (range 27–84)), and six age groups: 0–40 years (103); 41–50 years (68); 51–60 years (90); 61–72 years (92); 71–80 years (66); +80 years (20). The location of the listed neoplastic lesions is also indicated: NiN, non-invasive neoplasia; A, gastric antrum, both anterior and posterior walls; IA, incisura angularis; B, gastric body, both anterior and posterior walls. | ||||||||
| Sex | ||||||||
| Male | 211 | 29 | 55 | 33 | 49 | 41 | 26 | 7 |
| Female | 228 | 36 | 48 | 35 | 41 | 51 | 40 | 13 |
| H pylori status | ||||||||
| Hp+ve | 187 | 20 | 38 | 27 | 42 | 45 | 25 | 10 |
| Hp−ve/naïve | 192 | 29 | 59 | 36 | 32 | 31 | 25 | 9 |
| Hp-eradicated | 60 | 16 | 6 | 5 | 16 | 16 | 16 | 1 |
| Peptic ulcer | ||||||||
| Gastric (scar) | 5 (3) | 4 (3) | 0 | 0 | 1 (0) | 2 (1) | 2 (2) | 0 |
| Duodenal (scar) | 29 (7) | 2 (1) | 7 (0) | 4 (2) | 7 (3) | 2 (1) | 5 (0) | 4 (1) |
| Neoplasia | ||||||||
| Indefinite NiN | 2 | 0 | 0 | 0 | 1 (A, A) | 1 | 0 | 0 |
| Low-grade NiN | 3 | 1 | 0 | 0 | 0 | 2 (A, IA) | 1 (B) | 0 |
| High-grade NiN | 1 | 0 | 0 | 0 | 0 | 0 | 1 (IA) | 0 |
| Invasive cancer | 1 | 1 | 0 | 0 | 0 | 1 (A-IA) | 0 | 0 |